Analyst picks & changes

By BC Staff | Apr 17, 1995 | 7:00 AM GMT

Biogen Inc.

(BGEN)

Merrill Lynch analyst Jeffrey Casdin said that research by PathoGenesis Inc. showing a link between human herpes virus-6 and multiple sclerosis could dim prospects for

Read the full 280 word article

How to gain access

Continue reading with a
two-week free trial.